In 1967, a new era in endocrinology was born. A set of pulse chase experiments performed by Steiner and Oyer (1) elegantly showed, for the first time, that insulin was derived from a larger precursor molecule, proinsulin. The radical revelation, that bioactive peptides are derived from larger precursors, forever changed endocrinology and, from then on, the concept of hormone precursors (or prohormones) has become a central dogma. Subsequently, the use of both traditional protein sequence studies and recombinant DNA technology have provided definitive structures for the precursors of all the known bioactive peptides as well as identifying several previously unknown precursors, the function of which are still not fully understood. In general, all these molecules contain within their sequence one or more copies of the active peptide while some contain several different bioactive peptides. In addition, they undergo a series of highly regulated post-translational events that includes specific proteolytic cleavage and modifications such as amidation, acetylation and phophorylation. These post-translational processing events are especially interesting because there are a number of examples where the extent of processing can yield very different bioactive peptides from the same precursor. Probably the best example of this phenomenon, and arguably the most studied prohormone, is the ACTH precursor pro-opiomelanocortin (POMC). This short review aims to highlight why it has been of such interest to (neuro)endocrinologists and suggests that it still has a few more secrets to yield.
Discovery of POMCThe discovery of POMC ( Fig. 1) was preceded by a number of what, at the time, appeared to be unrelated observations. Both ACTH and a-melanocyte-stimulating hormone (a-MSH) had been purified and sequenced from the pituitaries of various species. However, the fact that a-MSH has the same amino acid sequence as the first 13 residues of ACTH was not seen to be of much significance until the isolation of corticotrophin-like intermediate peptide (CLIP) (2), the peptide that comprises the C-terminal of ACTH. This, together with the identification of larger molecular weight forms of immunoreactive ACTH (3, 4), began to suggest that ACTH and a-MSH were indeed derived from the same molecule.A further observation suggesting the existence of a common precursor to a number of pituitary hormones was that the sequence of the newly-discovered pituitary peptide, b-endorphin (5, 6), which had strong opiate-like activity, shared the same sequence as the C-terminal of b-lipotrophin (b-LPH), another pituitary hormone released under the same conditions as ACTH. It was subsequently shown that b-LPH was expressed in the same pituitary cells as a-MSH and CLIP (7).In 1976, the first published report came that suggested ACTH and b-LPH were derived from the same molecule (8) It is just over 30 years since the definitive identification of the adrenocorticotrophin (ACTH) precursor, pro-opiomelanocotin (POMC). Although first characterised in the anterior and...